Since propiconazole meets the criteria for being very persistent (vP) according to Annex XIII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council [Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC (OJ L 396, 30.12.2006, p. 1).], and meets the criteria for classification as skin sensitiser category 1 as defined in Annex I to Regulation (EC) No 1272/2008 of the European Parliament and of the Council [Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (OJ L 353, 31.12.2008, p. 1).], treated articles treated with or incorporating propiconazole should be appropriately labelled when placed on the market.
Recital 7, Regulation (EU) 2015/1609
In forcesince 24 Sep 2015
Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 Decembe…Law
Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 Decembe…Law
- celex=31967L0548
- celex=31976L0769
- celex=31991L0155
- celex=31993L0067
- celex=31993L0105
- celex=31993R0793
- celex=31994R1488
- celex=31999L0045
- celex=32000L0021
- num:eu=1967/548